Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
In recent years, recombinant adenoviral and adeno-associated viral (AAV) vectors have been exploited in a number of gene delivery approaches. The use of these vectors in clinical gene transfer has increased the demand for their characterization, production and purification. Although the classical method of adenovirus or AAV purification by density gradient centrifugation is effective on a small scale, chromatographic separation is the most versatile and powerful method for large-scale production of recombinant adenovirus or AAV. This review describes different chromatographic modes for adenovirus or AAV purification and process development, as well as the utility of different purification steps for virus production. Advances in the development of viral vectors for gene therapy, such as the discovery of new AAV serotypes, adenoviral and AAV retargeting and improved production of helper-dependent adenoviral vectors, require further development of efficient purification methods.
Burova
E
E
Regeneron Parmaceuticals Inc., Tarrytown, NY, USA.
Ioffe
E
E
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D001709:Biotechnology / Q000379:methods*; D002845:Chromatography / Q000379:methods; D004274:DNA, Recombinant / Q000302:isolation & purification; D004279:DNA, Viral / Q000302:isolation & purification; D000229:Dependovirus / Q000235:genetics*; D005822:Genetic Vectors / Q000302:isolation & purification*; D006801:Humans; D011786:Quality Control; D014773:Virology / Q000379:methods
D004274:DNA, Recombinant; D004279:DNA, Viral